missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies Purvalanol A
Click to view available options
Quantity:
10 mg
Unit Size:
10mg
Description
- Purvalanol A is a cell-permeable, potent, and selective inhibitor of cyclin-dependent kinases (CDKs)
- CDKs and cyclins form a stoichiometric complex which is necessary for the CDK subunit to gain its protein kinase activity
- It has been shown that these CDK/cyclin complexes play a key role in initiating G2/M transitions of the cell cycle (Jackman & Pines)
- Purvalanol A acts through competitive inhibition of ATP binding, to inhibit CDK1/cyclin B (IC50 = 4 nM), CDK2/cyclin A (IC50 = 70 nM), CDK2/cyclin E (IC50 = 35 nM), CDK4/cyclin D1 (IC50 = 850 nM) and CDK5-p35 (IC50 = 75 nM; Bain et al.; Gray et al.), thereby arresting cells in G1 and G2
- Inhibits proliferation in exponentially growing cancer cell lines and reversibly arrests synchronised cells in G1 and G2 phase of cell cycle (Villerbu et al.)
- Induces apoptosis in MCF-7 estrogen receptor positive breast cancer cells (Obakan et al.)
- Suppresses cancer progression associated with Src up-regulation by the coordinated inhibition of cell cycle progression and tyrosine kinase signaling (Hikita et al.)
Specifications
Specifications
| CAS | 212844-53-6 |
| Synonym | NG 60 |
| Quantity | 10 mg |
| Molecular Formula | C19H25ClN6O |
| Purity | ≥98% |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction